Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

• मुख्य लेखकों: Zijian Zhou (लेखक), Takuya Nagashima (लेखक), Chihiro Toda (लेखक), Mone Kobayashi (लेखक), Takahide Suzuki (लेखक), Kazuki Nagayasu (लेखक), Hisashi Shirakawa (लेखक), Satoshi Asai (लेखक), Shuji Kaneko (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic homeostasis, usually characterized by increased low-density lipoprotein (LDL) cholesterol and triglycerides, and accompanied...